Trading Day Review: LENZ Therapeutics Inc. (LENZ) Gains Momentum, Closing at 18.41

For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The price of LENZ Therapeutics Inc. (NASDAQ: LENZ) closed at $18.41 in the last session, up 1.94% from day before closing price of $18.06. In other words, the price has increased by $1.94 from its previous closing price. On the day, 1.23 million shares were traded. LENZ stock price reached its highest trading level at $18.525 during the session, while it also had its lowest trading level at $17.44.

Ratios:

We take a closer look at LENZ’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 39.20 and its Current Ratio is at 39.20. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $32.

On April 10, 2024, Citigroup started tracking the stock assigning a Buy rating and target price of $34.Citigroup initiated its Buy rating on April 10, 2024, with a $34 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on May 14 ’24 when Chevallard Daniel R. bought 3,188 shares for $15.68 per share. The transaction valued at 49,988 led to the insider holds 3,188 shares of the business.

MCCOLLUM JAMES W bought 31,332 shares of LENZ for $501,093 on May 13 ’24. The Director now owns 525,565 shares after completing the transaction at $15.99 per share. On Mar 21 ’24, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the Director of the company, bought 998,009 shares for $15.03 each. As a result, the insider paid 15,000,075 and bolstered with 3,319,339 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LENZ now has a Market Capitalization of 470090144 and an Enterprise Value of 257399376.

Stock Price History:

Over the past 52 weeks, LENZ has reached a high of $24.59, while it has fallen to a 52-week low of $9.51. The 50-Day Moving Average of the stock is 8.41%, while the 200-Day Moving Average is calculated to be 31.73%.

Shares Statistics:

According to the various share statistics, LENZ traded on average about 159.97K shares per day over the past 3-months and 285910 shares per day over the past 10 days. A total of 25.53M shares are outstanding, with a floating share count of 18.34M. Insiders hold about 28.16% of the company’s shares, while institutions hold 58.87% stake in the company. Shares short for LENZ as of 1715731200 were 1074262 with a Short Ratio of 8.03, compared to 1713139200 on 307948.

Most Popular